Vascular & Endovascular

Cardiovascular risk factors have similar effects on the incidence of coronary heart disease (CHD) and ischemic stroke in women, researchers report in the first large-scale study of its kind in female patients.

Patients with peripheral artery disease (PAD) and a history of lower extremity revascularization (LER) face an increased risk of both cardiac and limb ischemic events and subsequent revascularization, according to research published in the Journal of the American College of Cardiology Oct. 2.

A Russian study that analyzed the process of blood coagulation in humans at different life stages has found hemostasis in newborn babies is particularly delicate—something that, paired with other common risks, can boost an infant’s risk of thrombosis early in life.

A Hillsborough County Fire Rescue paramedic has been fired and three others suspended without pay after a 10-week investigation concluded they failed to adequately care for a stroke patient who later died, the Tampa Bay Times reported this week.

Targeted plasticity therapy (TPT)—a novel approach to stroke treatment that involves stimulating the vagus nerve to accelerate plasticity in the brain—can double stroke patients’ rates of upper limb recovery, according to research published in Stroke. Paired with traditional motor-skill rehabilitation, it’s twice as effective as standard therapy.

Stem cells in the embryo, previously thought to mature into only red blood or immune system cells, have another function, according to new research out of University College London. They can differentiate into endothelial cells, too, and could help in the growth of blood vessels in developing fetuses.

The Eluvia drug-eluting vascular stent system has been approved by the FDA, device maker Boston Scientific announced Sept. 24—just two days after results from the IMPERIAL trial were presented at the Transcatheter Cardiovascular Therapeutics 2018 meeting.

Height—and the genes that influence it—are important predictors for the development of varicose veins, according to a study out of Stanford University.

Resolute Onyx, a polymer-coated zotarolimus-eluting stent, has been proven safe and effective in an all-comer population of more than 2,000 heart patients, according to late-breaking results of the BIONYX trial.

Atrial fibrillation patients are acutely aware of their five-fold increased risk of stroke, new research from suggests—and 38 percent report feeling “trapped” between their fear of having a stroke and the major bleeding risks associated with anticoagulants.

Patients who suffer from deep vein thrombosis (DVT) see a “clear benefit” from initiating preventive compression therapy shortly after their diagnosis, as opposed to later stages of treatment, according to a study published this week in the journal Blood.

Risk-adjustment models assessing hospitals’ stroke outcomes should include patient transfer status, argue the authors of a new study, who found centers that accepted more transfer patients treated a sicker population and experienced higher mortality rates.